Please see the Provider Notice, which includes updates to the TennCare Preferred Drug List, Clinical Criteria, and Interim Criteria below for November 2021. These changes go into effect on November 1.
- BaG removals: Clindesse
- Added to non-preferred: Suboxone, Clindesse
- Added to preferred: buprenorphine-naloxone film (BESMART only), cinacalcet
- Modified criteria/quantity limits for Emflaza, Xeljanz, Xeljanz solution, Xeljanz XR, Olumiant, Rinvoq
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.